openPR Logo
Press release

Global Peptide Therapeutics Market 2016 Analysis, Trends and Forecasts 2024

05-08-2017 10:33 PM CET | Health & Medicine

Press release from: Transparency Market Research

Global Peptide Therapeutics Market 2016 Analysis, Trends

According to a new research report by Transparency Market Research (TMR), market players with large revenue base, such as Sanofi, Eli Lilly, Novo Nordisk, and Teva, have been dominating the global peptide therapeutics market. In 2015, these companies together held a share of more than 75% in this market.

These market players are conducting rigorous research and have taken up various development initiatives to accentuate their respective market shares, which is likely to increase the competition within this market, reports the research study.

Browse the full Peptide Therapeutics Market (Application - Cancer, Metabolic, CVD, Respiratory, GIT, Anti-infective, Dermatology, CNS, and Renal; Route of Administration – Parenteral and Oral; Type - Innovative and Generic; Technology - Liquid Phase, Solid Phase, and Hybrid Phase; Type of Molecule - Vasopressin, Somatostatin, Calcitonin, and Natriuretic, Immunopeptide; API Peptide Type - In-house and CMO) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024 report at http://www.transparencymarketresearch.com/tuberculosis-testing-market.html

As per TMR’s estimations, the opportunity in the worldwide market for peptide therapeutics was worth US$21.3 bn in 2015. The market is expected to expand at a CAGR of 9.10% during the period from 2016 and 2024 and reach US$46.6 mn by the end of the forecast period. The demand for peptide therapeutics is significantly high for the treatment of cancer. Researchers at TMR expect the trend to remain so over the next few years.

Immunopeptides to Report Significant Growth

The report analyzes the global market for peptide therapeutics on the basis of a number of market parameters. One among them is the type of molecule, based on which, the market has been classified into vasopressin, somatostatin, calcitonin, natriuretic, and immunopeptide. Thanks to the increasing usage of immunopeptide for the treatment of several conditions, such as cancer and tumors, the immunopeptide segment has been registering a higher growth than others.

Since the treatment of these diseases is complex, more investments is being made by the key market players in research and development of various therapies, amongst which the immuno therapy is the most favored one. This, as a result is anticipated to reflect positively on the growth of the immunopeptide segment in the near future, notes the study.

In terms of the geography, the report segments the worldwide market for peptide therapeutics into the Middle East and Africa, Latin America, North America, Europe, and Asia Pacific. In 2015, North America acquired the leading position in the global market with a share of 38.8%. Researchers expect this regional market to retain its position over the period of the forecast, thanks to the infrastructural advancements in the medical and healthcare industry. The emergence of peptide therapeutics as a highly potent drugs for the treatment of cancer and various other diseases and the presence of large pool of leading players in the U.S. are also projected to boost the North America market for peptide therapeutics in the years to come.

Increasing Usage of Peptides in Cancer Treatment to Boost Market’s Growth

“The rising prevalence of cancer is the key factor behind the significant growth of the global peptide therapeutics market,” states a TMR analyst. According to the WHO, nearly 7 million people die from cancer every year and there will be more than 16 million new cancer cases every year by 2020. Since chemotherapy is facing major challenges due to its inability to deliver the correct amount of drug directly, the application of peptides in cancer treatment has increased, opening new avenues for future growth.

Get accurate market forecast and analysis on the Global Peptide Therapeutics Market. Request a sample to stay abreast on the key trends impacting this market.

http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=418

Going forward, the rising incidence rate of metabolic disorders is likely to create lucrative opportunities for market players in the years to come. However, the lack of regulatory standards may restrict the market from growing steading over the next few years, states the research report.

The study presented here is based on a report by Transparency Market Research (TMR), titled “Peptide Therapeutics Market (Application - Cancer, Metabolic, CVD, Respiratory, GIT, Anti-infective, Dermatology, CNS, and Renal; Route of Administration - Parenteral and Oral; Type - Innovative and Generic; Technology - Liquid Phase, Solid Phase, and Hybrid Phase; Type of Molecule - Vasopressin, Somatostatin, Calcitonin, and Natriuretic, Immunopeptide; API Peptide Type - In-house and CMO) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024.”

The global peptide therapeutics market has been segmented into:

By Application

Cancer
Metabolic
CVD
Respiratory
GIT
Anti-infective
Dermatology
CNS
Renal
Others
By Route of Administration

Parenteral
Oral
Others
By Type

Innovative
Generic
By Technology

Liquid Phase
Solid Phase
Hybrid Phase
By Type of Molecule

Vasopressin
Somatostatin
Calcitonin
Immunopeptide
Natriuretic
Others
By API Peptide Type

In-house
CMO
By Geography

North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe
Asia Pacific (APAC)
Japan
China
India
Rest of APAC
Latin America (LATAM)
Brazil
Mexico
Rest of LATAM
Middle East & Africa (MEA)
South Africa
Saudi Arabia
Rest of MEA

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Peptide Therapeutics Market 2016 Analysis, Trends and Forecasts 2024 here

News-ID: 528333 • Views:

More Releases from Transparency Market Research

Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Study
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Stud …
The global 𝐭𝐢𝐬𝐬𝐮𝐞 𝐛𝐚𝐧𝐤𝐢𝐧𝐠 𝐦𝐚𝐫𝐤𝐞𝐭 reached a value of US$ 1,056.4 million in 2017 and is projected to nearly triple to US$ 2,903.3 million by 2026, with a robust Compound Annual Growth Rate (CAGR) of approximately 12.0% from 2018 to 2026. Factors such as increasing awareness about tissue donation, technological advancements, and a growing target patient population are anticipated to propel market growth during this period. Moreover, the market is expected
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
This report by Transparency Market Research, Inc. assesses the present state and future growth potential of the global 𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐜𝐥𝐨𝐬𝐮𝐫𝐞 𝐝𝐞𝐯𝐢𝐜𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭. It features a comprehensive executive summary, offering insights into various segments of the market. Additionally, the report provides detailed analysis and data on product, access type, application, end user, and regional segments within the global market. Vascular closure devices is estimated to reach a value of ~US$ 1 Bn
Digital Health Market Estimated at US$ 1.1 Trillion by 2031, TMR Study
Digital Health Market Estimated at US$ 1.1 Trillion by 2031, TMR Study
In 2022, the worldwide 𝐃𝐢𝐠𝐢𝐭𝐚𝐥 𝐇𝐞𝐚𝐥𝐭𝐡 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲 garnered a valuation of US$ 382.5 billion. Projections indicate a steady growth trajectory, with a compound annual growth rate (CAGR) of 13.1% anticipated from 2023 to 2031, ultimately culminating in a total valuation of US$ 1.1 trillion by the conclusion of 2031. Market analysts foresee a promising outlook characterized by the burgeoning prevalence of chronic diseases and the increasing adoption of smartphones and internet
Global Data Center Networking Market Set to Surge, Forecasted to Reach US$ 56.3 …
The Data Center Networking Market is poised for remarkable growth, driven by the burgeoning demand for cloud-native applications and the rapid adoption of data center virtualization and cloud computing. With an estimated value of US$20.6 billion in 2021, the market is projected to surge at a robust CAGR of 10.8% from 2022 to 2031, reaching a staggering US$56.3 billion by the end of 2031. Get Sample Copy of This Report at:

All 5 Releases


More Releases for Peptide

Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established
What's driving the Customized Peptide Synthesis Market Growth? | Key Players are …
The customized peptide synthesis market is projected to generate a revenue of $390.0 million by 2024 as per a recent P&S Intelligence study. The market is being progressively driven by technological innovations, growing burden of cancer and infectious diseases, increasing investments and funding for protein-based research, and rising research activities in synthetic biology. Download free report sample at: https://www.psmarketresearch.com/market-analysis/customized-peptide-synthesis-market/report-sample There are two main types of products available in the customized peptide synthesis
Customized Peptide Synthesis Market 2019-2024 by Top Key Players are GenScript, …
Customized peptide synthesis market is forecasted to generate revenue of $390.0 million by 2024. The market is mainly driven by increasing investments and funding for protein-based research, technological innovations, growing burden of cancer and infectious diseases, and increasing research activities in the field of synthetic biology. Download free report sample at: https://www.psmarketresearch.com/market-analysis/customized-peptide-synthesis-market/report-sample The different types of products available in the customized peptide synthesis market are reagents and equipment. Reagents category is expected
Peptide Synthesis Market Increasing Demand & Latest Trend with Genscript, AnaSpe …
HTF MI recently introduced United States Peptide Synthesis Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2023. The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are Bachem, PolyPeptide, GL Biochem, Xinbang, Hybio, USVPeptides, Thermofischer, ScinoPharm, Genscript,
Global Peptide Therapeutics Market: Cancer Treatment to Surface as Key Applicati …
Market Research Reports Search Engine (MRRSE) has been acting as an impressive data source when it comes to evaluating various industrial verticals. The research report titled “Global Peptide Therapeutics Market” offers a clear insight about the Peptide Therapeutics assessed over the global platform. This analysis proves beneficial for readers & new investors who are aiming to enter the market for Peptide Therapeutics in the near future. Click to Request a Sample:
Peptide Based Cancer Therapeutics Marke For peptide based cancer therapeutics ov …
About Peptide Based Cancer Therapeutics Market Popularity of peptide based cancer therapeutics is on the rise, owing to the positive outlook on their efficiency in treating cancer. According to the latest report published by Fact.MR, the global market for peptide based cancer therapeutics is set to reflect an above average CAGR during 2017 to 2022, to reach a valuation in excess of US$ 11,100 Mn. Incessant development in drug